Takashi Kei Kishimoto - 04 Jan 2023 Form 4 Insider Report for SELECTA BIOSCIENCES INC (RNAC)

Role: Chief Scientific Officer
Signature: /s/ Matthew Bartholomae, Attorney-in-Fact for Takashi Kei Kishimoto
Issuer symbol: RNAC
Transactions as of: 04 Jan 2023
Net transactions value: -$11,077
Form type: 4
Filing time: 06 Jan 2023, 16:15:52 UTC
Previous filing: 04 Jan 2023
Next filing: 01 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SELB	Common Stock	Sale	$7,234	-6,381	-1.7%	$1.13	367,719	04 Jan 2023	Direct	F1
transaction	SELB	Common Stock	Sale	$12.6	-11	-0%	$1.14	367,708	04 Jan 2023	Direct	F1
transaction	SELB	Common Stock	Sale	$3,808	-3,372	-0.92%	$1.13	364,336	05 Jan 2023	Direct	F1
transaction	SELB	Common Stock	Sale	$22.23	-20	-0.01%	$1.11	364,316	05 Jan 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.